Relaxin-2 in Cardiometabolic Diseases: Mechanisms of Action and Future Perspectives
Despite the great effort of the medical community during the last decades, cardiovascular diseases remain the leading cause of death worldwide, increasing their prevalence every year mainly due to our new way of life. In the last years, the study of new hormones implicated in the regulation of energ...
Main Authors: | Sandra Feijóo-Bandín, Alana Aragón-Herrera, Diego Rodríguez-Penas, Manuel Portolés, Esther Roselló-Lletí, Miguel Rivera, José R. González-Juanatey, Francisca Lago |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-08-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphys.2017.00599/full |
Similar Items
-
Adipokines and Inflammation: Focus on Cardiovascular Diseases
by: Sandra Feijóo-Bandín, et al.
Published: (2020-10-01) -
Die Relaxin-Plasmakonzentration als prognostischer Marker bei Hündinnen mit Mammatumoren
by: Schweizer, Stephan
Published: (2010) -
The role of the relaxin receptor RXFP1 in brain cancer
by: Kunanuvat, Usakorn
Published: (2013) -
The role of the relaxin receptor RXFP1 in brain cancer
by: Kunanuvat, Usakorn
Published: (2013) -
The role of relaxin-3/RXFP3 system in hyperphagia
by: De Avila Dal'Bo, Camila
Published: (2019)